Clinical Trial Update: A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of BPN-14770 in healthy young and elderly adults; the study is completed. Alzheimer's disease is listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BPN-14770 (BPN-14770)

Snippet

Sponsor: Tetra Discovery Partners | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED